{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:56:07Z","timestamp":1790812567897,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126954","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T01:35:46Z","timestamp":1741484146000},"page":"126954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparison of Streptococcus pneumoniae nasopharyngeal colonization, serotype-specific and protein-specific antibody and cytokine levels in young children prior to, during and post COVID-19 pandemic"],"prefix":"10.1016","volume":"54","author":[{"given":"Naoko","family":"Fuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank N.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bajorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pichichero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126954_bb0005","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.12688\/f1000research.9283.1","article-title":"Epidemiology, virulence factors and management of the pneumococcus","volume":"5","author":"Feldman","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.vaccine.2025.126954_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2013.08.061","article-title":"Colonisation endpoints in Streptococcus pneumoniae vaccine trials","volume":"32","author":"Auranen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126954_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.643326","article-title":"Virus-induced changes of the respiratory tract environment promote secondary infections with Streptococcus pneumoniae","volume":"11","author":"Sender","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/cid\/ciab382","article-title":"Substantial decline in invasive pneumococcal disease during coronavirus disease 2019 pandemic in Hong Kong","volume":"74","author":"Teng","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0025","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1093\/cid\/ciaa1728","article-title":"Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective National Cohort Study, England","volume":"72","author":"Amin-Chowdhury","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126954_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab1014","article-title":"Decline in pneumococcal disease in young children during the COVID-19 pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study","volume":"75","author":"Danino","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.722483","article-title":"COVID-19 pandemic impact on respiratory infectious diseases in primary care practice in children","volume":"9","author":"Kaur","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.vaccine.2025.126954_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10096-021-04324-0","article-title":"Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015-2019","volume":"41","author":"Kaur","year":"2022","journal-title":"European j clin microbiol & infectious diseases\u202f: official publication of the European Soc Clin Microbiol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0050","unstructured":"Heather J., Adam G.T., Martin Irene, Gonzalez Mark D., Ledeboer Nathan A., Cools Piet, et al. ASM ClinMicroNow 2023. Section II Bacteriology. doi\/10.1128\/9781683670438.MCM.ch22."},{"key":"10.1016\/j.vaccine.2025.126954_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jpids\/piad004","article-title":"Colonization, density, and antibiotic resistance of Streptococcus pneumoniae, Haemophilus Influenzae, and Moraxella catarrhalis among PCV13-vaccinated infants in the first six months of life in Rochester, New York: a cohort study","volume":"12","author":"Kaur","year":"2023","journal-title":"J Ped Infectious Dis Soc"},{"key":"10.1016\/j.vaccine.2025.126954_bb0060","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2020.04.063","article-title":"Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine","volume":"38","author":"Kaur","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126954_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/INF.0000000000000949","article-title":"Otitis-prone Children Have Immunologic Deficiencies in Naturally Acquired Nasopharyngeal Mucosal Antibody Response after Streptococcus pneumoniae Colonization","volume":"35","author":"Xu","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.126954_bb0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0167-4889(98)00177-3","article-title":"Interleukin-4 (IL-4), but not IL-10, regulates the synthesis of IL-6, IL-8 and leukemia inhibitory factor by human bone marrow stromal cells","volume":"1449","author":"Denizot","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2025.126954_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2172-12-25","article-title":"Activated IL-23\/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients","volume":"12","author":"Wang","year":"2011","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/labinvest.3700716","article-title":"NOD2: a potential target for regulating liver injury","volume":"88","author":"Body-Malapel","year":"2008","journal-title":"Lab Investig"},{"key":"10.1016\/j.vaccine.2025.126954_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cyto.2013.11.002","article-title":"IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals","volume":"65","author":"Nakagawa","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2025.126954_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013077","article-title":"Evaluation of a quantitative real-time PCR assay to measure HIV-specific mucosal CD8+ T cell responses in the cervix","volume":"5","author":"Chege","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126954_bb0095","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.29.2100706","article-title":"Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021","volume":"26","author":"Weinberger Opek","year":"2021","journal-title":"Euro Surveill"},{"issue":"225\u20136","key":"10.1016\/j.vaccine.2025.126954_bb0100","article-title":"Epidemiologic changes caused by the preventive measures for the coronavirus disease 2019 pandemic: an additional challenge for pediatricians","volume":"252","author":"Pettoello-Mantovani","year":"2023","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2025.126954_bb0105","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00431-021-03968-6","article-title":"Bronchiolitis in COVID-19 times: a nearly absent disease?","volume":"180","author":"Van Brusselen","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2025.126954_bb0110","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/cid\/cix941","article-title":"Dynamics of bacterial colonization with Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection","volume":"66","author":"DeMuri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1200617","article-title":"Changing patterns of infectious diseases in children during the COVID-19 pandemic","volume":"13","author":"Yang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0120","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-058556","article-title":"Window of susceptibility to acute otitis media infection","volume":"151","author":"Bajorski","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.126954_bb0125","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.18959","article-title":"Association of Nonpharmaceutical Interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France","volume":"5","author":"Rybak","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.126954_bb0130","article-title":"Infant pneumococcal carriage in Belgium not affected by COVID-19 containment measures","volume":"11","author":"Willen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126954_bb0135","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/infdis\/jiae184","article-title":"Pneumococci isolated from children in community-based practice differ from isolates identified by population and laboratory-based invasive disease surveillance","volume":"230","author":"Kaur","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.744742","article-title":"Transition of serotype 35B pneumococci from commensal to prevalent virulent strain in children","volume":"11","author":"Fuji","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0145","first-page":"11","article-title":"Lower density and shorter duration of nasopharyngeal carriage by pneumococcal serotype 1 (ST217) may explain its increased invasiveness over other serotypes","author":"Bricio-Moreno","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2025.126954_bb0150","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0155","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae","volume":"189","author":"Sandgren","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0160","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/jama.2023.26608","article-title":"From \u201cImmunity Debt\u201d to \u201cImmunity Theft\u201d-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges","volume":"331","author":"Rubin","year":"2024","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2025.126954_bb0165","first-page":"53","article-title":"Exploring immunity debt: dynamic alterations in RSV antibody levels in children under 5 years during the COVID-19 pandemic","volume":"88","author":"Jiang","year":"2024","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2025.126954_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1473-3099(22)00763-0","article-title":"Decline of RSV-specific antibodies during the COVID-19 pandemic","volume":"23","author":"den Hartog","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0175","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/infdis\/jiac192","article-title":"Waning immunity against respiratory syncytial virus during the coronavirus disease 2019 pandemic","volume":"226","author":"Reicherz","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12985-024-02326-w","article-title":"Antigenic drift and immunity gap explain reduction in protective responses against influenza a(H1N1)pdm09 and a(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023","volume":"21","author":"Fossum","year":"2024","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2025.126954_bb0185","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1128\/JVI.01833-14","article-title":"Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus","volume":"88","author":"Wolf","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0190","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1128\/JVI.02455-14","article-title":"Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph node","volume":"89","author":"Wu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0195","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.2000094","article-title":"Influenza infection induces alveolar macrophage dysfunction and thereby enables noninvasive Streptococcus pneumoniae to cause deadly pneumonia","volume":"205","author":"Verma","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0200","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection","volume":"14","author":"Sun","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.126954_bb0205","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.4049\/jimmunol.167.9.5240","article-title":"TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia","volume":"167","author":"Rijneveld","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0210","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1128\/IAI.00224-15","article-title":"Sensing of interleukin-1 cytokines during Streptococcus pneumoniae colonization contributes to macrophage recruitment and bacterial clearance","volume":"83","author":"Lemon","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126954_bb0215","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/intimm\/dxn071","article-title":"Contribution of IL-1 to resistance to Streptococcus pneumoniae infection","volume":"20","author":"Kafka","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1574-695X.2012.00931.x","article-title":"Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis","volume":"64","author":"Duell","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0225","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.4049\/jimmunol.172.12.7603","article-title":"IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection","volume":"172","author":"van der Sluijs","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.126954_bb0235","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2025.126954_bb0240","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.smim.2007.10.009","article-title":"Th17 cells and mucosal host defense","volume":"19","author":"Aujla","year":"2007","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0245","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/infdis\/175.3.497","article-title":"Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells","volume":"175","author":"Saito","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126954_bb0250","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1128\/JVI.72.6.4756-4764.1998","article-title":"Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus","volume":"72","author":"Olszewska-Pazdrak","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.126954_bb0255","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric infectious disease group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?","volume":"51","author":"Cohen","year":"2021","journal-title":"Infectious diseases now"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25002518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25002518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:20:37Z","timestamp":1750342837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25002518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"alternative-id":["S0264410X25002518"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126954","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Streptococcus pneumoniae nasopharyngeal colonization, serotype-specific and protein-specific antibody and cytokine levels in young children prior to, during and post COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126954"}}